Logout
 ACCP Evidence-Based
 Guidelines and Products
 HSP Functions and
 Processes
 Guideline Development
 Processes
   HSP Publications and
   Related Editorials on
   Guideline Development
   Panel selection and
   Conflict of Interest:
   An Overview
   Roles and
   Responsibilities
   of Panel Members
   Guideline Topic
   Selection Criteria
   Defining Research
   Questions
   Reviewing the Evidence
   The ACCP Grading
   System for Guideline
   Recommendations
   Appraising Guidelines
   Writing and Formatting
   Instructions
   Review of Guidelines
   General Timeline for
   Guideline Development
 Suggest a Future
 Guideline Topic
 Request for ACCP
 Endorsement of
 Guidelines
 HSP Calendar
 External Resources
 Contact HSP Staff
 
 

Health and Science Policy and Evidence-Based Medicine

Defining Research Questions

It is critical that the panel and methodologist develop research questions that are narrow, specific, and can be addressed through the literature. Research questions should include:

  • The patient population(s)
  • The control group
  • The exposure(s) or intervention(s)
  • Outcomes
  • Clarification of inclusion criteria

The following is an example of a research question that is too broad:

  • Are antiplatelet agents effective in preventing vascular events in patients with vascular disease?

The following is an example of a research question that is more narrow and specific:

  • In patients presenting for possible diagnosis of lung cancer, what is the reliability of fiber optic bronchoscopy for diagnosing central (endobronchial) lesions, peripheral lesions >2 cm in diameter, and peripheral lesions <2 cm in diameter?
  Patient Population Intervention or Exposure Control Group or Comparison Intervention Outcome(s)
Tips* Start by describing a group of similar patients.
Balance precision with brevity.

Ask, "Which main intervention should be considered?"

Be specific.
Ask, "Which is the main alternative to compare with the intervention?"
Be specific.

Ask, "Which can be accomplished?" or "What could this exposure/intervention really affect?"
Be specific.

Example "In patients with heart failure from dilated cardiomyopathy who are in sinus rhythm…?"

"…would adding anticoagulation with warfarin to standard heart failure therapy…?"

"…when compared with standard therapy alone…?"

"…lead to lower mortality or morbidity from thromboembolism. Is this enough to be worth the increased risk of bleeding?"

*Centre for Evidence-based Medicine.